share_log

Morgan Stanley Upgrades Third Harmonic Bio to Overweight, Raises Price Target to $20

Benzinga ·  Aug 9 05:28  · Ratings

Morgan Stanley analyst Michael Ulz upgrades Third Harmonic Bio (NASDAQ:THRD) from Equal-Weight to Overweight and raises the price target from $12 to $20.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment